Targeting IL-6 effective in RA poor responders to anti-TNF inhibitors

SAN FRANCISCO – Sarilumab, an investigational monoclonal antibody directed against the IL-6 receptor, demonstrated efficacy at two different dose levels, compared with placebo, in patients with...